2025. Nephrotic syndrome with sunitinib-associated focal segmental glomerulosclerosis in a patient with renal carcinoma: partial reversibility after dose adjustment: Case Report. Revista de la Sociedad Ecuatoriana de Nefrología, Diálisis y Trasplante. 13, 2 (Aug. 2025), 149–156. DOI:https://doi.org/10.56867/118.